Search results
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 6 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 2 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 1 day agoThe approval under the agency's accelerated process was based on an early- to mid-stage study, in...
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers | Texarkana Gazette
Texarkana Gazette· 1 day agoThe Food and Drug Administration on Friday authorized the first...flavors can reduce the harms of traditional tobacco smoking. The FDA said it authorized ...
Johnson & Johnson submits BLA to FDA for lung cancer drug
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe company applied a fixed formulation comprising amivantamab and recombinant...human hyaluronidase...
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer - AstraZeneca (NASDAQ:AZN)
Benzinga· 6 days agoThe U.S. Food and Drug Administration’s (FDA) approval is specifically for adults with primary,...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 5 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
FDA approves 1st menthol e-cigarettes, saying they could help adult smokers
WJZY via Yahoo News· 2 days agoThe Food and Drug Administration on Friday authorized the first menthol-flavored electronic...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
FDA Expands Durvalumab Label to Endometrial Cancer
Medscape· 6 days agoThe approval for mismatch repair deficient newly diagnosed advanced or recurrent endometrial cancer was based on improved progression-free survival vs...